431 related articles for article (PubMed ID: 30043491)
21. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
[TBL] [Abstract][Full Text] [Related]
22. URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway.
Cai J; Li R; Xu X; Zhang L; Wu S; Yang T; Fang L; Wu J; Zhu X; Li M; Huang Y
Oncotarget; 2015 Nov; 6(34):36489-504. PubMed ID: 26429875
[TBL] [Abstract][Full Text] [Related]
23. Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-κB signaling pathway.
Li J; Li Y; Wang B; Ma Y; Chen P
J Biomed Sci; 2017 Dec; 24(1):95. PubMed ID: 29233161
[TBL] [Abstract][Full Text] [Related]
24. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
[TBL] [Abstract][Full Text] [Related]
25. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.
Li Y; He LR; Gao Y; Zhou NN; Liu Y; Zhou XK; Liu JF; Guan XY; Ma NF; Xie D
Cell Death Dis; 2019 Feb; 10(2):99. PubMed ID: 30718500
[TBL] [Abstract][Full Text] [Related]
26. ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer.
Fu T; Ji K; Jin L; Zhang J; Wu X; Ji X; Fan B; Jia Z; Wang A; Liu J; Bu Z; Ji J
Gastric Cancer; 2021 Jan; 24(1):45-59. PubMed ID: 32572790
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.
Alvarez SE; Harikumar KB; Hait NC; Allegood J; Strub GM; Kim EY; Maceyka M; Jiang H; Luo C; Kordula T; Milstien S; Spiegel S
Nature; 2010 Jun; 465(7301):1084-8. PubMed ID: 20577214
[TBL] [Abstract][Full Text] [Related]
28. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of TRAF6 reveals a conserved functional role of the RING dimerization interface and a potentially necessary but insufficient role of RING-dependent TRAF6 polyubiquitination towards NF-κB activation.
Megas C; Hatzivassiliou EG; Yin Q; Marinopoulou E; Hadweh P; Vignali DA; Mosialos G
Cell Signal; 2011 May; 23(5):772-7. PubMed ID: 21185369
[TBL] [Abstract][Full Text] [Related]
30. TRIM47 is a novel endothelial activation factor that aggravates lipopolysaccharide-induced acute lung injury in mice via K63-linked ubiquitination of TRAF2.
Qian Y; Wang Z; Lin H; Lei T; Zhou Z; Huang W; Wu X; Zuo L; Wu J; Liu Y; Wang LF; Guan XH; Deng KY; Fu M; Xin HB
Signal Transduct Target Ther; 2022 May; 7(1):148. PubMed ID: 35513381
[TBL] [Abstract][Full Text] [Related]
31. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
[TBL] [Abstract][Full Text] [Related]
32. Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.
Zheng M; Morgan-Lappe SE; Yang J; Bockbrader KM; Pamarthy D; Thomas D; Fesik SW; Sun Y
Cancer Res; 2008 Sep; 68(18):7570-8. PubMed ID: 18794145
[TBL] [Abstract][Full Text] [Related]
33. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
Imre G; Gekeler V; Leja A; Beckers T; Boehm M
Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
[TBL] [Abstract][Full Text] [Related]
36. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.
Borghi A; Verstrepen L; Beyaert R
Biochem Pharmacol; 2016 Sep; 116():1-10. PubMed ID: 26993379
[TBL] [Abstract][Full Text] [Related]
37. NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.
Blakely CM; Pazarentzos E; Olivas V; Asthana S; Yan JJ; Tan I; Hrustanovic G; Chan E; Lin L; Neel DS; Newton W; Bobb KL; Fouts TR; Meshulam J; Gubens MA; Jablons DM; Johnson JR; Bandyopadhyay S; Krogan NJ; Bivona TG
Cell Rep; 2015 Apr; 11(1):98-110. PubMed ID: 25843712
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of ribosomal protein S3 and antiapoptotic TRAF2 protein mediates radioresistance in non-small cell lung cancer cells.
Yang HJ; Youn H; Seong KM; Jin YW; Kim J; Youn B
J Biol Chem; 2013 Feb; 288(5):2965-75. PubMed ID: 23188828
[TBL] [Abstract][Full Text] [Related]
39. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.
Hu P; Han Z; Couvillon AD; Kaufman RJ; Exton JH
Mol Cell Biol; 2006 Apr; 26(8):3071-84. PubMed ID: 16581782
[TBL] [Abstract][Full Text] [Related]
40. miR-675 promotes disease progression of non-small cell lung cancer via activating NF-κB signaling pathway.
Feng Y; Yang C; Hu D; Wang X; Liu X
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):7-10. PubMed ID: 28719338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]